Hire Software Developer for Biotech Startups
Senior, direct, no layers

The scarcest resource at a biotech startup is focused scientific time. Every hour a scientist spends reformatting data, chasing a CRO, or rebuilding an investor update is an hour not spent on the science the company exists to do. The recurring friction is experimental data scattered across notebooks and drives, CRO results arriving late or in unusable formats, and investor updates rebuilt from scratch every month.

Custom software earns its cost only when it fits a workflow nothing else fits. The first job is to test that claim honestly — and to say so when an existing tool would do.

Picture a CRO dataset arriving in a format nobody can use, days before an investor update is due. In that situation, a system built around the actual workflow — with the edge cases handled and the audit trail in place — would replace a patchwork of spreadsheets and workarounds. Book a free discovery call and we will test the fit on one real workflow before any wider scope is agreed.

an electronic lab notebook such as Benchling, a LIMS, bioinformatics pipelines, and CRO data portals already cover much of the work at biotech startups. What is usually missing is the routine around them: consistent handoffs, visible status, and checks that catch errors before they reach research partners, investors, and CRO teams.

The system joins an electronic lab notebook such as Benchling and a LIMS through their interfaces, with data ownership and exports defined so the organization is never locked out of its own records. Hosting and monitoring are part of the delivery.

This page describes services, not scientific or regulatory advice. Research and regulatory decisions stay with the startup's qualified scientific staff. FDA IND and BLA pathways shapes what can be automated or changed, and the work is scoped to fit it rather than work around it.

For a startup like this, success looks like scientists spending time on science, partners getting clean data, and milestones documented well enough to survive diligence.

Two problems deserve naming: experimental data scattered across notebooks and drives and CRO results arriving late or in unusable formats. Both persist when the underlying routine stays manual and nobody owns the follow-up, so each deliverable in this engagement is paired with a named owner and a visible queue, and problems surface while they are still small.

What changes is the workaround count: fewer spreadsheets, fewer manual reconciliations, and one system the team trusts for assay development and validation.

Browse all hire engagements or discuss your biotech startup workflow directly.